AIM VACCINE News

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - UNBLINDING OF DATA FROM PHASE III CLINICAL TRIAL OF ITERATIVE SERUM-FREE RABIES VACCINE: PRE-DEFINED CLINICAL OBJECTIVES MET WITH GOOD IMMUNOGENICITY AND SAFETY

Oct 6 07:35 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 4 04:37 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 3 04:30 ET

AIM VACCINE: 2024 INTERIM REPORT

Aug 29 08:20 ET

AIM VACCINE: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 29 08:15 ET

AIM VACCINE: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Aug 29 08:11 ET

艾美疫苗：董事調任

Aug 29 08:09 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - OFFICIAL APPLICATION FOR CLINICAL TRIALS FORQUADRIVALENT INFLUENZA VIRUS VACCINE(MDCK CELLS) SUBMITTED

Aug 29 08:05 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - OFFICIAL APPLICATION FOR CLINICAL TRIALS FOR ABSORBED TETANUS VACCINE SUBMITTED

Aug 29 08:01 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATIONS FOR CLINICAL TRIALS FOR MRNA RSV AND MRNA SHINGLES/HERPES ZOSTER VACCINES OF AIM VACCINE SUBMITTED TO FDA

Aug 29 07:57 ET

AIM VACCINE: NOTICE OF BOARD MEETING

Aug 19 04:57 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 2 04:45 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 05:45 ET

AIM VACCINE: VOLUNTARY ANNOUNCEMENT - PRE-APPLICATIONS FOR CLINICAL TRIALS FORTWO MRNA VACCINES OF RESPIRATORY SYNCYTIAL VIRUS (RSV)AND SHINGLES/HERPES ZOSTER OF AIM VACCINE SUBMITTED

Jun 4 09:38 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 4 04:33 ET

AIM VACCINE: POLL RESULTS OF THE ANNUAL GENERALMEETING HELD ON MAY 20, 2024

May 20 07:06 ET

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 05:08 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

May 7 05:01 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

May 7 04:53 ET

AIM VACCINE: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

May 7 04:46 ET